Multiple efforts are underway to improve cell therapies for cancer. During the MedCity News INVEST conference in Chicago, a panel discussed the future of cell therapies and what the industry doing to manage the financial risks of these new treatments.
The use of LLMs in healthcare is still quite new, so health systems want to deploy these tools in the least risky way possible. A panel of experts explained how they think health systems can do this during MedCity's INVEST conference — some of their advice included starting with deployment in nonclinical settings and partnering with incumbent vendors rather than startups.
Omada's new program provides coaching, peer support and educational materials to patients struggling with chronic obesity and taking GLP-1s. The company chose not to prescribe the weight loss drugs itself.
Learn how Diagnostic Robotics' AI-powered care management solution helped a regional Blues plan and affiliated hospitals save $1,600 PMPM in cost of care reduction per engaged member by proactively targeting impactable patients and providing optimized care pathways.
No comments